Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Peptides and combination thereof for use in the immunotherapy against cancers

Peptides and combination thereof for use in the immunotherapy against cancers

US Patent 11103534 · Granted Aug 31, 2021

Estimated economic value: $3,292,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Peptides displayed by HLA for use in immunotherapy against different types of ca2025
Peptides displayed by HLA for use in immunotherapy against different types of ca2025
Peptides displayed by HLA for use immunotherapy against different types of cance2025
Peptides displayed by HLA for use immunotherapy against different types of cance2025
Peptides displayed by HLA for use in immunotherapy against different types of ca2025
Peptides displayed by HLA for use in immunotherapy against different types of ca2025
Immunotherapy with B*08 restricted peptides and combination of peptides against 2025
Immunotherapy with B*07 restricted peptides and combination of peptides against 2025
Immunotherapy with A*01 restricted peptides and combination of peptides against 2025
Immunotherapy with B*07 restricted peptides and combination of peptides against 2025
B*44 restricted peptides for use in immunotherapy against cancers and related me2024
Peptides and combination of peptides for use in immunotherapy against ovarian ca2024